U.S. Capital Wealth Advisors, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1808915 AUSTIN, TX

Position in ALNY

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$8,118,557

-$2,754,386 QoQ

Shares Held

24,537

-10.3% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

U.S. Capital Wealth Advisors, LLC holds $11,669,198 across 6 Biotechnology names. ALNY ranks #1 (69.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc. This page	24,537	$8,118,557
2	VKTX	Viking Therapeutics, Inc.	66,780	$2,173,021
3	REGN	Regeneron Pharmaceuticals, Inc.	1,432	$1,106,420
4	SMMT	Summit Therapeutics Inc.	12,009	$227,690
5	ALDX	Aldeyra Therapeutics, Inc.	15,805	$26,710
6	IKT	Inhibikase Therapeutics, Inc.	10,000	$16,800

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,118,557	24,537	-10.3%	Shares	Sole	2026-04-07
2025-12-31	$10,872,943	27,343	-0.7%	Shares	Sole	2026-01-23
2025-09-30	$12,560,064	27,544	-47.1%	Shares	Sole	2025-10-09
2025-06-30	$16,965,484	52,027	-7.1%	Shares	Sole	2025-07-14
2025-03-31	$15,124,090	56,011	-7.4%	Shares	Sole	2025-04-29
2024-12-31	$14,236,490	60,501	-1.6%	Shares	Sole	2025-01-24
2024-09-30	$16,914,345	61,500	0.0%	Shares	Sole	2024-10-22
2024-06-30	$14,944,500	61,500	0.0%	Shares	Sole	2024-07-11
2024-03-31	$9,191,175	61,500	0.0%	Shares	Sole	2024-05-10
2023-12-31	$11,771,715	61,500	0.0%	Shares	Sole	2024-02-06
2023-09-30	$10,891,650	61,500	—	Shares	Sole	2023-10-19
No filing history on record for this holder in this stock.